116 related articles for article (PubMed ID: 27766872)
21. Targeting the OXE receptor with a selective antagonist inhibits allergen-induced pulmonary inflammation in non-human primates.
Cossette C; Miller LA; Ye Q; Chourey S; Reddy CN; Rokach J; Powell WS
Br J Pharmacol; 2022 Jan; 179(2):322-336. PubMed ID: 34766334
[TBL] [Abstract][Full Text] [Related]
22. Biological Roles of 5-Oxo-6,8,11,14-Eicosatetraenoic Acid and the OXE Receptor in Allergic Diseases: Collegium Internationale Allergologicum Update 2024.
Lin L; Dai F; Wei J; Chen Z
Int Arch Allergy Immunol; 2024; 185(4):301-310. PubMed ID: 38176394
[TBL] [Abstract][Full Text] [Related]
23. The OXE receptor: a new therapeutic approach for asthma?
Jones CE
Trends Mol Med; 2005 Jun; 11(6):266-70. PubMed ID: 15949767
[TBL] [Abstract][Full Text] [Related]
24. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent chemoattractant for human basophils.
Sturm GJ; Schuligoi R; Sturm EM; Royer JF; Lang-Loidolt D; Stammberger H; Amann R; Peskar BA; Heinemann A
J Allergy Clin Immunol; 2005 Nov; 116(5):1014-9. PubMed ID: 16275369
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress stimulates the synthesis of the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid by inflammatory cells.
Erlemann KR; Rokach J; Powell WS
J Biol Chem; 2004 Sep; 279(39):40376-84. PubMed ID: 15234979
[TBL] [Abstract][Full Text] [Related]
26. Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE.
Powell WS; Rokach J
Prog Lipid Res; 2005; 44(2-3):154-83. PubMed ID: 15893379
[TBL] [Abstract][Full Text] [Related]
27. TG1019/OXE, a Galpha(i/o)-protein-coupled receptor, mediates 5-oxo-eicosatetraenoic acid-induced chemotaxis.
Hosoi T; Sugikawa E; Chikada A; Koguchi Y; Ohnuki T
Biochem Biophys Res Commun; 2005 Sep; 334(4):987-95. PubMed ID: 16039985
[TBL] [Abstract][Full Text] [Related]
28. Expression and function of OXE receptor, an eicosanoid receptor, in steroidogenic cells.
Cooke M; Di Cónsoli H; Maloberti P; Cornejo Maciel F
Mol Cell Endocrinol; 2013 May; 371(1-2):71-8. PubMed ID: 23159987
[TBL] [Abstract][Full Text] [Related]
29. 5-Oxo-ETE receptor antagonists.
Gore V; Patel P; Chang CT; Sivendran S; Kang N; Ouedraogo YP; Gravel S; Powell WS; Rokach J
J Med Chem; 2013 May; 56(9):3725-32. PubMed ID: 23581530
[TBL] [Abstract][Full Text] [Related]
30. Base-dependent formation of cis and trans olefins and their application in the synthesis of 5-oxo-ETE receptor antagonists.
Gore V; Chourey S; Ye Q; Patel P; Ouedraogo Y; Gravel S; Powell WS; Rokach J
Bioorg Med Chem Lett; 2014 Aug; 24(15):3385-8. PubMed ID: 24948567
[TBL] [Abstract][Full Text] [Related]
31. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration.
Powell WS; Chung D; Gravel S
J Immunol; 1995 Apr; 154(8):4123-32. PubMed ID: 7706749
[TBL] [Abstract][Full Text] [Related]
32. Two Potent OXE-R Antagonists: Assignment of Stereochemistry.
Patel P; Reddy CN; Gore V; Chourey S; Ye Q; Ouedraogo YP; Gravel S; Powell WS; Rokach J
ACS Med Chem Lett; 2014 Jul; 5(7):815-9. PubMed ID: 25050171
[TBL] [Abstract][Full Text] [Related]
33. LTA(4)-derived 5-oxo-eicosatetraenoic acid: pH-dependent formation and interaction with the LTB(4) receptor of human polymorphonuclear leukocytes.
Falgueyret J; Riendeau D
Biochim Biophys Acta; 2000 Feb; 1484(1):51-8. PubMed ID: 10685030
[TBL] [Abstract][Full Text] [Related]
34. 5-oxo-6,8,11,14-eicosatetraenoic acid induces the infiltration of granulocytes into human skin.
Muro S; Hamid Q; Olivenstein R; Taha R; Rokach J; Powell WS
J Allergy Clin Immunol; 2003 Oct; 112(4):768-74. PubMed ID: 14564360
[TBL] [Abstract][Full Text] [Related]
35. 5-Oxo-ETE analogs and the proliferation of cancer cells.
O'Flaherty JT; Rogers LC; Paumi CM; Hantgan RR; Thomas LR; Clay CE; High K; Chen YQ; Willingham MC; Smitherman PK; Kute TE; Rao A; Cramer SD; Morrow CS
Biochim Biophys Acta; 2005 Oct; 1736(3):228-36. PubMed ID: 16154383
[TBL] [Abstract][Full Text] [Related]
36. Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis.
Powell WS; Ahmed S; Gravel S; Rokach J
J Allergy Clin Immunol; 2001 Feb; 107(2):272-8. PubMed ID: 11174193
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, molecular modelling studies and biological evaluation of new oxoeicosanoid receptor 1 agonists.
Stepniewski TM; Torrens-Fontanals M; Rodríguez-Espigares I; Giorgino T; Primdahl KG; Vik A; Stenstrøm Y; Selent J; Hansen TV
Bioorg Med Chem; 2018 Jul; 26(12):3580-3587. PubMed ID: 29866479
[TBL] [Abstract][Full Text] [Related]
38. 5-Oxo-6,8,11,14-eicosatetraenoic acid induces important eosinophil transmigration through basement membrane components: comparison of normal and asthmatic eosinophils.
Guilbert M; Ferland C; Bossé M; Flamand N; Lavigne S; Laviolette M
Am J Respir Cell Mol Biol; 1999 Jul; 21(1):97-104. PubMed ID: 10385597
[TBL] [Abstract][Full Text] [Related]
39. 5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils.
Powell WS; Gravel S; Halwani F
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):163-70. PubMed ID: 9870930
[TBL] [Abstract][Full Text] [Related]
40. International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor.
Brink C; Dahlén SE; Drazen J; Evans JF; Hay DW; Rovati GE; Serhan CN; Shimizu T; Yokomizo T
Pharmacol Rev; 2004 Mar; 56(1):149-57. PubMed ID: 15001665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
